The global Bupivacaine Hydrochloride for Injection market was valued at US$ 478 million in 2023 and is anticipated to reach US$ 659 million by 2030, witnessing a CAGR of 4.8% during the forecast period 2024-2030.

Bupivacaine Hydrochloride for Injection Market

Bupivacaine hydrochloride for injection is a local anesthetic primarily used for local infiltration anesthesia, peripheral nerve blocks, and epidural anesthesia. Developed by Hospira, it was first approved for use in the United States in 1972. This drug offers a long-lasting anesthetic effect, effectively alleviating pain during surgical procedures, and is widely used in various surgical and obstetric applications.

North American market for Bupivacaine Hydrochloride for Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Bupivacaine Hydrochloride for Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global manufacturers of Bupivacaine Hydrochloride for Injection include Pfizer, Fresenius Kabi, Hikma Pharmaceuticals, Baxter, Eugia Pharma, Hunan Zhengqing Pharmaceutical, Shanghai Harvest Pharmaceutical, Anhui Changjiang Pharmaceutical, Shanghai Zhaohui Pharmaceutical, Shandong Hualu Pharmaceutical, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Bupivacaine Hydrochloride for Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bupivacaine Hydrochloride for Injection.

The Bupivacaine Hydrochloride for Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Bupivacaine Hydrochloride for Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Bupivacaine Hydrochloride for Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Bupivacaine Hydrochloride for Injection Market Report

Report Metric	Details
Report Name	Bupivacaine Hydrochloride for Injection Market
Accounted market size in 2023	US$ 478 million
Forecasted market size in 2030	US$ 659 million
CAGR	4.8%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	2.5mg/ml 5mg/ml 7.5mg/ml
Segment by Application	Hospital Clinic Others
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Pfizer, Fresenius Kabi, Hikma Pharmaceuticals, Baxter, Eugia Pharma, Hunan Zhengqing Pharmaceutical, Shanghai Harvest Pharmaceutical, Anhui Changjiang Pharmaceutical, Shanghai Zhaohui Pharmaceutical, Shandong Hualu Pharmaceutical
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Bupivacaine Hydrochloride for Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Bupivacaine Hydrochloride for Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Bupivacaine Hydrochloride for Injection Market growing?

Ans: The Bupivacaine Hydrochloride for Injection Market witnessing a CAGR of 4.8% during the forecast period 2024-2030.

What is the Bupivacaine Hydrochloride for Injection Market size in 2030?

Ans: The Bupivacaine Hydrochloride for Injection Market size in 2030 will be US$ 659 million.

Who are the main players in the Bupivacaine Hydrochloride for Injection Market report?

Ans: The main players in the Bupivacaine Hydrochloride for Injection Market are Pfizer, Fresenius Kabi, Hikma Pharmaceuticals, Baxter, Eugia Pharma, Hunan Zhengqing Pharmaceutical, Shanghai Harvest Pharmaceutical, Anhui Changjiang Pharmaceutical, Shanghai Zhaohui Pharmaceutical, Shandong Hualu Pharmaceutical

What are the Application segmentation covered in the Bupivacaine Hydrochloride for Injection Market report?

Ans: The Applications covered in the Bupivacaine Hydrochloride for Injection Market report are Hospital, Clinic, Others

What are the Type segmentation covered in the Bupivacaine Hydrochloride for Injection Market report?

Ans: The Types covered in the Bupivacaine Hydrochloride for Injection Market report are 2.5mg/ml, 5mg/ml, 7.5mg/ml

1 Bupivacaine Hydrochloride for Injection Market Overview

1.1 Product Definition

1.2 Bupivacaine Hydrochloride for Injection by Type

1.2.1 Global Bupivacaine Hydrochloride for Injection Market Value Comparison by Type (2024-2030)

1.2.2 2.5mg/ml

1.2.3 5mg/ml

1.2.4 7.5mg/ml

1.3 Bupivacaine Hydrochloride for Injection by Application

1.3.1 Global Bupivacaine Hydrochloride for Injection Market Value by Application (2024-2030)

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Others

1.4 Global Bupivacaine Hydrochloride for Injection Market Size Estimates and Forecasts

1.4.1 Global Bupivacaine Hydrochloride for Injection Revenue 2019-2030

1.4.2 Global Bupivacaine Hydrochloride for Injection Sales 2019-2030

1.4.3 Global Bupivacaine Hydrochloride for Injection Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Bupivacaine Hydrochloride for Injection Market Competition by Manufacturers

2.1 Global Bupivacaine Hydrochloride for Injection Sales Market Share by Manufacturers (2019-2024)

2.2 Global Bupivacaine Hydrochloride for Injection Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Bupivacaine Hydrochloride for Injection Average Price by Manufacturers (2019-2024)

2.4 Global Key Players of Bupivacaine Hydrochloride for Injection, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Bupivacaine Hydrochloride for Injection, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Bupivacaine Hydrochloride for Injection, Product Type & Application

2.7 Global Key Manufacturers of Bupivacaine Hydrochloride for Injection, Date of Enter into This Industry

2.8 Global Bupivacaine Hydrochloride for Injection Market Competitive Situation and Trends

2.8.1 Global Bupivacaine Hydrochloride for Injection Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Bupivacaine Hydrochloride for Injection Players Market Share by Revenue

2.8.3 Global Bupivacaine Hydrochloride for Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Bupivacaine Hydrochloride for Injection Market Scenario by Region

3.1 Global Bupivacaine Hydrochloride for Injection Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Bupivacaine Hydrochloride for Injection Sales by Region: 2019-2030

3.2.1 Global Bupivacaine Hydrochloride for Injection Sales by Region: 2019-2024

3.2.2 Global Bupivacaine Hydrochloride for Injection Sales by Region: 2025-2030

3.3 Global Bupivacaine Hydrochloride for Injection Revenue by Region: 2019-2030

3.3.1 Global Bupivacaine Hydrochloride for Injection Revenue by Region: 2019-2024

3.3.2 Global Bupivacaine Hydrochloride for Injection Revenue by Region: 2025-2030

3.4 North America Bupivacaine Hydrochloride for Injection Market Facts & Figures by Country

3.4.1 North America Bupivacaine Hydrochloride for Injection Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Bupivacaine Hydrochloride for Injection Sales by Country (2019-2030)

3.4.3 North America Bupivacaine Hydrochloride for Injection Revenue by Country (2019-2030)

3.4.4 United States

3.4.5 Canada

3.5 Europe Bupivacaine Hydrochloride for Injection Market Facts & Figures by Country

3.5.1 Europe Bupivacaine Hydrochloride for Injection Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Bupivacaine Hydrochloride for Injection Sales by Country (2019-2030)

3.5.3 Europe Bupivacaine Hydrochloride for Injection Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Bupivacaine Hydrochloride for Injection Market Facts & Figures by Region

3.6.1 Asia Pacific Bupivacaine Hydrochloride for Injection Market Size by Region: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Bupivacaine Hydrochloride for Injection Sales by Region (2019-2030)

3.6.3 Asia Pacific Bupivacaine Hydrochloride for Injection Revenue by Region (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Bupivacaine Hydrochloride for Injection Market Facts & Figures by Country

3.7.1 Latin America Bupivacaine Hydrochloride for Injection Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Bupivacaine Hydrochloride for Injection Sales by Country (2019-2030)

3.7.3 Latin America Bupivacaine Hydrochloride for Injection Revenue by Country

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa Bupivacaine Hydrochloride for Injection Market Facts & Figures by Country

3.8.1 Middle East and Africa Bupivacaine Hydrochloride for Injection Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Bupivacaine Hydrochloride for Injection Sales by Country (2019-2030)

3.8.3 Middle East and Africa Bupivacaine Hydrochloride for Injection Revenue by Country

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Bupivacaine Hydrochloride for Injection Sales by Type (2019-2030)

4.1.1 Global Bupivacaine Hydrochloride for Injection Sales by Type (2019-2024)

4.1.2 Global Bupivacaine Hydrochloride for Injection Sales by Type (2025-2030)

4.1.3 Global Bupivacaine Hydrochloride for Injection Sales Market Share by Type (2019-2030)

4.2 Global Bupivacaine Hydrochloride for Injection Revenue by Type (2019-2030)

4.2.1 Global Bupivacaine Hydrochloride for Injection Revenue by Type (2019-2024)

4.2.2 Global Bupivacaine Hydrochloride for Injection Revenue by Type (2025-2030)

4.2.3 Global Bupivacaine Hydrochloride for Injection Revenue Market Share by Type (2019-2030)

4.3 Global Bupivacaine Hydrochloride for Injection Price by Type (2019-2030)

5 Segment by Application

5.1 Global Bupivacaine Hydrochloride for Injection Sales by Application (2019-2030)

5.1.1 Global Bupivacaine Hydrochloride for Injection Sales by Application (2019-2024)

5.1.2 Global Bupivacaine Hydrochloride for Injection Sales by Application (2025-2030)

5.1.3 Global Bupivacaine Hydrochloride for Injection Sales Market Share by Application (2019-2030)

5.2 Global Bupivacaine Hydrochloride for Injection Revenue by Application (2019-2030)

5.2.1 Global Bupivacaine Hydrochloride for Injection Revenue by Application (2019-2024)

5.2.2 Global Bupivacaine Hydrochloride for Injection Revenue by Application (2025-2030)

5.2.3 Global Bupivacaine Hydrochloride for Injection Revenue Market Share by Application (2019-2030)

5.3 Global Bupivacaine Hydrochloride for Injection Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Pfizer

6.1.1 Pfizer Company Information

6.1.2 Pfizer Description and Business Overview

6.1.3 Pfizer Bupivacaine Hydrochloride for Injection Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Pfizer Bupivacaine Hydrochloride for Injection Product Portfolio

6.1.5 Pfizer Recent Developments/Updates

6.2 Fresenius Kabi

6.2.1 Fresenius Kabi Company Information

6.2.2 Fresenius Kabi Description and Business Overview

6.2.3 Fresenius Kabi Bupivacaine Hydrochloride for Injection Sales, Revenue and Gross Margin (2019-2024)

6.2.4 Fresenius Kabi Bupivacaine Hydrochloride for Injection Product Portfolio

6.2.5 Fresenius Kabi Recent Developments/Updates

6.3 Hikma Pharmaceuticals

6.3.1 Hikma Pharmaceuticals Company Information

6.3.2 Hikma Pharmaceuticals Description and Business Overview

6.3.3 Hikma Pharmaceuticals Bupivacaine Hydrochloride for Injection Sales, Revenue and Gross Margin (2019-2024)

6.3.4 Hikma Pharmaceuticals Bupivacaine Hydrochloride for Injection Product Portfolio

6.3.5 Hikma Pharmaceuticals Recent Developments/Updates

6.4 Baxter

6.4.1 Baxter Company Information

6.4.2 Baxter Description and Business Overview

6.4.3 Baxter Bupivacaine Hydrochloride for Injection Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Baxter Bupivacaine Hydrochloride for Injection Product Portfolio

6.4.5 Baxter Recent Developments/Updates

6.5 Eugia Pharma

6.5.1 Eugia Pharma Company Information

6.5.2 Eugia Pharma Description and Business Overview

6.5.3 Eugia Pharma Bupivacaine Hydrochloride for Injection Sales, Revenue and Gross Margin (2019-2024)

6.5.4 Eugia Pharma Bupivacaine Hydrochloride for Injection Product Portfolio

6.5.5 Eugia Pharma Recent Developments/Updates

6.6 Hunan Zhengqing Pharmaceutical

6.6.1 Hunan Zhengqing Pharmaceutical Company Information

6.6.2 Hunan Zhengqing Pharmaceutical Description and Business Overview

6.6.3 Hunan Zhengqing Pharmaceutical Bupivacaine Hydrochloride for Injection Sales, Revenue and Gross Margin (2019-2024)

6.6.4 Hunan Zhengqing Pharmaceutical Bupivacaine Hydrochloride for Injection Product Portfolio

6.6.5 Hunan Zhengqing Pharmaceutical Recent Developments/Updates

6.7 Shanghai Harvest Pharmaceutical

6.7.1 Shanghai Harvest Pharmaceutical Company Information

6.7.2 Shanghai Harvest Pharmaceutical Description and Business Overview

6.7.3 Shanghai Harvest Pharmaceutical Bupivacaine Hydrochloride for Injection Sales, Revenue and Gross Margin (2019-2024)

6.7.4 Shanghai Harvest Pharmaceutical Bupivacaine Hydrochloride for Injection Product Portfolio

6.7.5 Shanghai Harvest Pharmaceutical Recent Developments/Updates

6.8 Anhui Changjiang Pharmaceutical

6.8.1 Anhui Changjiang Pharmaceutical Company Information

6.8.2 Anhui Changjiang Pharmaceutical Description and Business Overview

6.8.3 Anhui Changjiang Pharmaceutical Bupivacaine Hydrochloride for Injection Sales, Revenue and Gross Margin (2019-2024)

6.8.4 Anhui Changjiang Pharmaceutical Bupivacaine Hydrochloride for Injection Product Portfolio

6.8.5 Anhui Changjiang Pharmaceutical Recent Developments/Updates

6.9 Shanghai Zhaohui Pharmaceutical

6.9.1 Shanghai Zhaohui Pharmaceutical Company Information

6.9.2 Shanghai Zhaohui Pharmaceutical Description and Business Overview

6.9.3 Shanghai Zhaohui Pharmaceutical Bupivacaine Hydrochloride for Injection Sales, Revenue and Gross Margin (2019-2024)

6.9.4 Shanghai Zhaohui Pharmaceutical Bupivacaine Hydrochloride for Injection Product Portfolio

6.9.5 Shanghai Zhaohui Pharmaceutical Recent Developments/Updates

6.10 Shandong Hualu Pharmaceutical

6.10.1 Shandong Hualu Pharmaceutical Company Information

6.10.2 Shandong Hualu Pharmaceutical Description and Business Overview

6.10.3 Shandong Hualu Pharmaceutical Bupivacaine Hydrochloride for Injection Sales, Revenue and Gross Margin (2019-2024)

6.10.4 Shandong Hualu Pharmaceutical Bupivacaine Hydrochloride for Injection Product Portfolio

6.10.5 Shandong Hualu Pharmaceutical Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Bupivacaine Hydrochloride for Injection Industry Chain Analysis

7.2 Bupivacaine Hydrochloride for Injection Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Bupivacaine Hydrochloride for Injection Production Mode & Process

7.4 Bupivacaine Hydrochloride for Injection Sales and Marketing

7.4.1 Bupivacaine Hydrochloride for Injection Sales Channels

7.4.2 Bupivacaine Hydrochloride for Injection Distributors

7.5 Bupivacaine Hydrochloride for Injection Customers

8 Bupivacaine Hydrochloride for Injection Market Dynamics

8.1 Bupivacaine Hydrochloride for Injection Industry Trends

8.2 Bupivacaine Hydrochloride for Injection Market Drivers

8.3 Bupivacaine Hydrochloride for Injection Market Challenges

8.4 Bupivacaine Hydrochloride for Injection Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Hospira

Pfizer Inc

Fresenius Kabi

Hikma Pharmaceuticals

Baxter

Eugia Pharma

Hunan Zhengqing Pharmaceutical

Shanghai Harvest Pharmaceutical

Anhui Changjiang Pharmaceutical

Shanghai Zhaohui Pharmaceutical

Shandong Hualu Pharmaceutical

List of Tables

Table 1. Global Bupivacaine Hydrochloride for Injection Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Bupivacaine Hydrochloride for Injection Market Value by Application (2024-2030) & (US$ Million)

Table 3. Global Bupivacaine Hydrochloride for Injection Market Competitive Situation by Manufacturers in 2023

Table 4. Global Bupivacaine Hydrochloride for Injection Sales (K Units) of Key Manufacturers (2019-2024)

Table 5. Global Bupivacaine Hydrochloride for Injection Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Bupivacaine Hydrochloride for Injection Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Bupivacaine Hydrochloride for Injection Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Bupivacaine Hydrochloride for Injection Average Price (US$/Unit) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Bupivacaine Hydrochloride for Injection, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Bupivacaine Hydrochloride for Injection, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Bupivacaine Hydrochloride for Injection, Product Type & Application

Table 12. Global Key Manufacturers of Bupivacaine Hydrochloride for Injection, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Bupivacaine Hydrochloride for Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bupivacaine Hydrochloride for Injection as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Bupivacaine Hydrochloride for Injection Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Bupivacaine Hydrochloride for Injection Sales by Region (2019-2024) & (K Units)

Table 18. Global Bupivacaine Hydrochloride for Injection Sales Market Share by Region (2019-2024)

Table 19. Global Bupivacaine Hydrochloride for Injection Sales by Region (2025-2030) & (K Units)

Table 20. Global Bupivacaine Hydrochloride for Injection Sales Market Share by Region (2025-2030)

Table 21. Global Bupivacaine Hydrochloride for Injection Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Bupivacaine Hydrochloride for Injection Revenue Market Share by Region (2019-2024)

Table 23. Global Bupivacaine Hydrochloride for Injection Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Bupivacaine Hydrochloride for Injection Revenue Market Share by Region (2025-2030)

Table 25. North America Bupivacaine Hydrochloride for Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Bupivacaine Hydrochloride for Injection Sales by Country (2019-2024) & (K Units)

Table 27. North America Bupivacaine Hydrochloride for Injection Sales by Country (2025-2030) & (K Units)

Table 28. North America Bupivacaine Hydrochloride for Injection Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Bupivacaine Hydrochloride for Injection Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Bupivacaine Hydrochloride for Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Bupivacaine Hydrochloride for Injection Sales by Country (2019-2024) & (K Units)

Table 32. Europe Bupivacaine Hydrochloride for Injection Sales by Country (2025-2030) & (K Units)

Table 33. Europe Bupivacaine Hydrochloride for Injection Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Bupivacaine Hydrochloride for Injection Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Bupivacaine Hydrochloride for Injection Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Bupivacaine Hydrochloride for Injection Sales by Region (2019-2024) & (K Units)

Table 37. Asia Pacific Bupivacaine Hydrochloride for Injection Sales by Region (2025-2030) & (K Units)

Table 38. Asia Pacific Bupivacaine Hydrochloride for Injection Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Bupivacaine Hydrochloride for Injection Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Bupivacaine Hydrochloride for Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Bupivacaine Hydrochloride for Injection Sales by Country (2019-2024) & (K Units)

Table 42. Latin America Bupivacaine Hydrochloride for Injection Sales by Country (2025-2030) & (K Units)

Table 43. Latin America Bupivacaine Hydrochloride for Injection Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Bupivacaine Hydrochloride for Injection Revenue Market Share by Country (2019-2024)

Table 45. Middle East and Africa Bupivacaine Hydrochloride for Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East and Africa Bupivacaine Hydrochloride for Injection Sales by Country (2019-2024) & (K Units)

Table 47. Middle East and Africa Bupivacaine Hydrochloride for Injection Sales by Country (2025-2030) & (K Units)

Table 48. Middle East and Africa Bupivacaine Hydrochloride for Injection Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East and Africa Bupivacaine Hydrochloride for Injection Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Bupivacaine Hydrochloride for Injection Sales (K Units) by Type (2019-2024)

Table 51. Global Bupivacaine Hydrochloride for Injection Sales (K Units) by Type (2025-2030)

Table 52. Global Bupivacaine Hydrochloride for Injection Sales Market Share by Type (2019-2024)

Table 53. Global Bupivacaine Hydrochloride for Injection Sales Market Share by Type (2025-2030)

Table 54. Global Bupivacaine Hydrochloride for Injection Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Bupivacaine Hydrochloride for Injection Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Bupivacaine Hydrochloride for Injection Revenue Market Share by Type (2019-2024)

Table 57. Global Bupivacaine Hydrochloride for Injection Revenue Market Share by Type (2025-2030)

Table 58. Global Bupivacaine Hydrochloride for Injection Price (US$/Unit) by Type (2019-2024)

Table 59. Global Bupivacaine Hydrochloride for Injection Price (US$/Unit) by Type (2025-2030)

Table 60. Global Bupivacaine Hydrochloride for Injection Sales (K Units) by Application (2019-2024)

Table 61. Global Bupivacaine Hydrochloride for Injection Sales (K Units) by Application (2025-2030)

Table 62. Global Bupivacaine Hydrochloride for Injection Sales Market Share by Application (2019-2024)

Table 63. Global Bupivacaine Hydrochloride for Injection Sales Market Share by Application (2025-2030)

Table 64. Global Bupivacaine Hydrochloride for Injection Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Bupivacaine Hydrochloride for Injection Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Bupivacaine Hydrochloride for Injection Revenue Market Share by Application (2019-2024)

Table 67. Global Bupivacaine Hydrochloride for Injection Revenue Market Share by Application (2025-2030)

Table 68. Global Bupivacaine Hydrochloride for Injection Price (US$/Unit) by Application (2019-2024)

Table 69. Global Bupivacaine Hydrochloride for Injection Price (US$/Unit) by Application (2025-2030)

Table 70. Pfizer Company Information

Table 71. Pfizer Description and Business Overview

Table 72. Pfizer Bupivacaine Hydrochloride for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 73. Pfizer Bupivacaine Hydrochloride for Injection Product

Table 74. Pfizer Recent Developments/Updates

Table 75. Fresenius Kabi Company Information

Table 76. Fresenius Kabi Description and Business Overview

Table 77. Fresenius Kabi Bupivacaine Hydrochloride for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 78. Fresenius Kabi Bupivacaine Hydrochloride for Injection Product

Table 79. Fresenius Kabi Recent Developments/Updates

Table 80. Hikma Pharmaceuticals Company Information

Table 81. Hikma Pharmaceuticals Description and Business Overview

Table 82. Hikma Pharmaceuticals Bupivacaine Hydrochloride for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 83. Hikma Pharmaceuticals Bupivacaine Hydrochloride for Injection Product

Table 84. Hikma Pharmaceuticals Recent Developments/Updates

Table 85. Baxter Company Information

Table 86. Baxter Description and Business Overview

Table 87. Baxter Bupivacaine Hydrochloride for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 88. Baxter Bupivacaine Hydrochloride for Injection Product

Table 89. Baxter Recent Developments/Updates

Table 90. Eugia Pharma Company Information

Table 91. Eugia Pharma Description and Business Overview

Table 92. Eugia Pharma Bupivacaine Hydrochloride for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 93. Eugia Pharma Bupivacaine Hydrochloride for Injection Product

Table 94. Eugia Pharma Recent Developments/Updates

Table 95. Hunan Zhengqing Pharmaceutical Company Information

Table 96. Hunan Zhengqing Pharmaceutical Description and Business Overview

Table 97. Hunan Zhengqing Pharmaceutical Bupivacaine Hydrochloride for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 98. Hunan Zhengqing Pharmaceutical Bupivacaine Hydrochloride for Injection Product

Table 99. Hunan Zhengqing Pharmaceutical Recent Developments/Updates

Table 100. Shanghai Harvest Pharmaceutical Company Information

Table 101. Shanghai Harvest Pharmaceutical Description and Business Overview

Table 102. Shanghai Harvest Pharmaceutical Bupivacaine Hydrochloride for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 103. Shanghai Harvest Pharmaceutical Bupivacaine Hydrochloride for Injection Product

Table 104. Shanghai Harvest Pharmaceutical Recent Developments/Updates

Table 105. Anhui Changjiang Pharmaceutical Company Information

Table 106. Anhui Changjiang Pharmaceutical Description and Business Overview

Table 107. Anhui Changjiang Pharmaceutical Bupivacaine Hydrochloride for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 108. Anhui Changjiang Pharmaceutical Bupivacaine Hydrochloride for Injection Product

Table 109. Anhui Changjiang Pharmaceutical Recent Developments/Updates

Table 110. Shanghai Zhaohui Pharmaceutical Company Information

Table 111. Shanghai Zhaohui Pharmaceutical Description and Business Overview

Table 112. Shanghai Zhaohui Pharmaceutical Bupivacaine Hydrochloride for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 113. Shanghai Zhaohui Pharmaceutical Bupivacaine Hydrochloride for Injection Product

Table 114. Shanghai Zhaohui Pharmaceutical Recent Developments/Updates

Table 115. Shandong Hualu Pharmaceutical Company Information

Table 116. Shandong Hualu Pharmaceutical Description and Business Overview

Table 117. Shandong Hualu Pharmaceutical Bupivacaine Hydrochloride for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 118. Shandong Hualu Pharmaceutical Bupivacaine Hydrochloride for Injection Product

Table 119. Shandong Hualu Pharmaceutical Recent Developments/Updates

Table 120. Key Raw Materials Lists

Table 121. Raw Materials Key Suppliers Lists

Table 122. Bupivacaine Hydrochloride for Injection Distributors List

Table 123. Bupivacaine Hydrochloride for Injection Customers List

Table 124. Bupivacaine Hydrochloride for Injection Market Trends

Table 125. Bupivacaine Hydrochloride for Injection Market Drivers

Table 126. Bupivacaine Hydrochloride for Injection Market Challenges

Table 127. Bupivacaine Hydrochloride for Injection Market Restraints

Table 128. Research Programs/Design for This Report

Table 129. Key Data Information from Secondary Sources

Table 130. Key Data Information from Primary Sources

Table 131. Authors List of This Report

List of Figures

Figure 1. Product Picture of Bupivacaine Hydrochloride for Injection

Figure 2. Global Bupivacaine Hydrochloride for Injection Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Bupivacaine Hydrochloride for Injection Market Share by Type: 2023 & 2030

Figure 4. 2.5mg/ml Product Picture

Figure 5. 5mg/ml Product Picture

Figure 6. 7.5mg/ml Product Picture

Figure 7. Global Bupivacaine Hydrochloride for Injection Market Value by Application (2024-2030) & (US$ Million)

Figure 8. Global Bupivacaine Hydrochloride for Injection Market Share by Application: 2023 & 2030

Figure 9. Hospital

Figure 10. Clinic

Figure 11. Others

Figure 12. Global Bupivacaine Hydrochloride for Injection Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 13. Global Bupivacaine Hydrochloride for Injection Market Size (2019-2030) & (US$ Million)

Figure 14. Global Bupivacaine Hydrochloride for Injection Sales (2019-2030) & (K Units)

Figure 15. Global Bupivacaine Hydrochloride for Injection Average Price (US$/Unit) & (2019-2030)

Figure 16. Bupivacaine Hydrochloride for Injection Report Years Considered

Figure 17. Bupivacaine Hydrochloride for Injection Sales Share by Manufacturers in 2023

Figure 18. Global Bupivacaine Hydrochloride for Injection Revenue Share by Manufacturers in 2023

Figure 19. Global 5 and 10 Largest Bupivacaine Hydrochloride for Injection Players: Market Share by Revenue in Bupivacaine Hydrochloride for Injection in 2023

Figure 20. Bupivacaine Hydrochloride for Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 21. Global Bupivacaine Hydrochloride for Injection Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 22. North America Bupivacaine Hydrochloride for Injection Sales Market Share by Country (2019-2030)

Figure 23. North America Bupivacaine Hydrochloride for Injection Revenue Market Share by Country (2019-2030)

Figure 24. United States Bupivacaine Hydrochloride for Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 25. Canada Bupivacaine Hydrochloride for Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 26. Europe Bupivacaine Hydrochloride for Injection Sales Market Share by Country (2019-2030)

Figure 27. Europe Bupivacaine Hydrochloride for Injection Revenue Market Share by Country (2019-2030)

Figure 28. Germany Bupivacaine Hydrochloride for Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 29. France Bupivacaine Hydrochloride for Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. U.K. Bupivacaine Hydrochloride for Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. Italy Bupivacaine Hydrochloride for Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 32. Russia Bupivacaine Hydrochloride for Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 33. Asia Pacific Bupivacaine Hydrochloride for Injection Sales Market Share by Region (2019-2030)

Figure 34. Asia Pacific Bupivacaine Hydrochloride for Injection Revenue Market Share by Region (2019-2030)

Figure 35. China Bupivacaine Hydrochloride for Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 36. Japan Bupivacaine Hydrochloride for Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. South Korea Bupivacaine Hydrochloride for Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. India Bupivacaine Hydrochloride for Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. Australia Bupivacaine Hydrochloride for Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. China Taiwan Bupivacaine Hydrochloride for Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. Southeast Asia Bupivacaine Hydrochloride for Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. Latin America Bupivacaine Hydrochloride for Injection Sales Market Share by Country (2019-2030)

Figure 43. Mexico Bupivacaine Hydrochloride for Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. Brazil Bupivacaine Hydrochloride for Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 45. Argentina Bupivacaine Hydrochloride for Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 46. Colombia Bupivacaine Hydrochloride for Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 47. Middle East and Africa Bupivacaine Hydrochloride for Injection Sales Market Share by Country (2019-2030)

Figure 48. Middle East and Africa Bupivacaine Hydrochloride for Injection Revenue Market Share by Country (2019-2030)

Figure 49. Turkey Bupivacaine Hydrochloride for Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 50. Saudi Arabia Bupivacaine Hydrochloride for Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 51. UAE Bupivacaine Hydrochloride for Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 52. Global Sales Market Share of Bupivacaine Hydrochloride for Injection by Type (2019-2030)

Figure 53. Global Revenue Market Share of Bupivacaine Hydrochloride for Injection by Type (2019-2030)

Figure 54. Global Bupivacaine Hydrochloride for Injection Price (US$/Unit) by Type (2019-2030)

Figure 55. Global Sales Market Share of Bupivacaine Hydrochloride for Injection by Application (2019-2030)

Figure 56. Global Revenue Market Share of Bupivacaine Hydrochloride for Injection by Application (2019-2030)

Figure 57. Global Bupivacaine Hydrochloride for Injection Price (US$/Unit) by Application (2019-2030)

Figure 58. Bupivacaine Hydrochloride for Injection Value Chain

Figure 59. Bupivacaine Hydrochloride for Injection Production Process

Figure 60. Channels of Distribution (Direct Vs Distribution)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Ibuprofen Sodium API Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-30X13296

Fri Mar 21 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global Enteric Gelatin Hollow Capsule Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-11U13426

Fri Mar 21 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global Tranexamic Acid Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-17W7451

Fri Mar 21 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global Moxifloxacin HCl Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

120 Pages

Type: Report

Code: QYRE-Auto-13144

Fri Mar 21 00:00:00 UTC 2025

$8000

Enterprise User

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions